Summary
This observational cohort study evaluated whether the use of extracorporeal membrane oxygenation as a bridge to lung transplantation affects the magnitude of improvement in patient-reported outcomes postoperatively. As suggested by the title, the analysis indicated that ECMO bridging status did not significantly impact the trajectory of patient-reported quality-of-life improvements following successful transplantation, suggesting that bridge-to-transplant strategy may not compromise functional recovery.
UK applicability
Findings are relevant to UK transplant centres performing lung transplantation and using ECMO bridging protocols, though applicability depends on similar patient selection criteria and postoperative management protocols in NHS transplant units.
Key measures
Patient-reported outcome measures (PROM) before and after transplantation; functional status and quality of life assessments
Outcomes reported
The study assessed changes in patient-reported quality of life and functional outcomes after lung transplantation, comparing recipients who received extracorporeal membrane oxygenation (ECMO) as a bridge to transplantation with those who did not.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.